Randomized phase III study comparing gefitinib (G) with erlotinib (E) in patients (pts) with previously treated advanced lung adenocarcinoma (LA): WJOG 5108L.Nobuyuki Katakami, Takashi Seto, Yoshiko Urata et al.|Journal of Clinical Oncology|2014Cited by 11
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA studyShigeru Tanzawa, Nobuhiko Seki, Hiroshige Yoshioka et al.|Therapeutic Advances in Medical Oncology|2025Cited by 3